Seed-Stage AI-Powered Personalized Health & Longevity Testing Service (Relocatable)

This is an opportunity to acquire a seed-stage, tech-enabled health service specializing in advanced, comprehensive diagnostics for longevity and disease prevention. The service leverages AI and advanced medical technology (including full-body MRI, whole-genome sequencing, and specialized biomarker testing) to provide members with deep insights into their health risks and performance goals. The operations are fully remote and scalable nationwide and globally. The seller notes strong unit economics and recurring revenue potential. Management is willing to stay post-acquisition, making this ideal for growth operators or investors seeking entry into the personalized medicine sector. No medical background is required to operate the business.